Regenerative medicine for the treatment of spinal cord injury: More than just promises?

Journal of Cellular and Molecular Medicine

Volumn 16, Issue 11, 2012, Pages 2564-2582

  Pêgo, Ana Paula ^a,b   Kubinova, Sarka ^c   Cizkova, Dasa ^d,e   Vanicky, Ivo ^d,e   Mar, Fernando Milhazes ^f   Sousa, Mónica Mendes ^f   Sykova, Eva ^a,g  

^a INEB INSTITUTO DE ENGENHARIA BIOMÉDICA   (Portugal)

^b UNIVERSITY OF PORTO   (Portugal)

^c INSTITUTE OF EXPERIMENTAL MEDICINE   (Czech Republic)

^d Center of Excellence for Brain Research   (Slovakia)

^e UNIVERSITY OF VETERINARY MEDICINE   (Slovakia)

^f UNIVERSITY OF PORTO   (Portugal)

^g CHARLES UNIVERSITY   (Czech Republic)

Author keywords

Biomaterials; Cell therapies; Clinical trials; Conditioning lesion; Gene therapy; Growth factors; Spinal cord injury; Stem cells

Indexed keywords

BIOMATERIAL;

ANIMAL; ARTICLE; EMBRYONIC STEM CELL; GENE THERAPY; HUMAN; HYDROGEL; METHODOLOGY; NERVE FIBER; NERVE REGENERATION; PATHOPHYSIOLOGY; PHYSIOLOGY; SCHWANN CELL; SPINAL CORD; SPINAL CORD INJURY; STEM CELL TRANSPLANTATION; TRANSPLANTATION;

ANIMALS; AXONS; BIOCOMPATIBLE MATERIALS; EMBRYONIC STEM CELLS; GENETIC THERAPY; HUMANS; HYDROGELS; NERVE REGENERATION; SCHWANN CELLS; SPINAL CORD; SPINAL CORD INJURIES; STEM CELL TRANSPLANTATION;

EID: 84868098934     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1582-4934.2012.01603.x     Document Type: Article

References (182)

1. Fitch MT, Silver J. CNS injury, glial scars, and inflammation: Inhibitory extracellular matrices and regeneration failure. Exp Neurol. 2008; 209: 294-301.
2. Ronaghi M, Erceg S, Moreno-Manzano V, et al. Challenges of stem cell therapy for spinal cord injury: human embryonic stem cells, endogenous neural stem cells, or induced pluripotent stem cells? Stem Cells. 2010; 28: 93-9.
3. Wyndaele M, Wyndaele JJ. Incidence, prevalence and epidemiology of spinal cord injury: what learns a worldwide literature survey? Spinal Cord. 2006; 44: 523-9.
4. Willerth SM, Sakiyama-Elbert SE. Cell therapy for spinal cord regeneration. Adv Drug Deliv Rev. 2008; 60: 263-76.
5. Hulsebosch CE. Recent advances in pathophysiology and treatment of spinal cord injury. Adv Physiol Educ. 2002; 26: 238-55.
6. Fawcett JW. Overcoming inhibition in the damaged spinal cord. J Neurotrauma. 2006; 23: 371-83.
7. Garcia-Alias G, Lin R, Akrimi SF, et al. Therapeutic time window for the application of chondroitinase ABC after spinal cord injury. Exp Neurol. 2008; 210: 331-8.
8. Muir EM, Fyfe I, Gardiner S, et al. Modification of N-glycosylation sites allows secretion of bacterial chondroitinase ABC from mammalian cells. J Biotechnol. 2010; 145: 103-10.
9. Barnabe-Heider F, Frisen J. Stem cells for spinal cord repair. Cell Stem Cell. 2008; 3: 16-24.
10. Bradbury EJ, McMahon SB. Spinal cord repair strategies: why do they work? Nat Rev Neurosci. 2006; 7: 644-53.
11. Xu XM, Onifer SM. Transplantation-mediated strategies to promote axonal regeneration following spinal cord injury. Respir Physiol Neurobiol. 2009; 169: 171-82.
12. Sykova E, Homola A, Mazanec R, et al. Autologous bone marrow transplantation in patients with subacute and chronic spinal cord injury. Cell Transplant. 2006; 15: 675-87.
13. Wright KT, Masri WE, Osman A, et al. Concise review: bone marrow for the treatment of spinal cord injury: mechanisms and clinical applications. Stem Cells. 2011; 29: 169-78.
14. Cizkova D, Kakinohana O, Kucharova K, et al. Functional recovery in rats with ischemic paraplegia after spinal grafting of human spinal stem cells. Neuroscience. 2007; 147: 546-60.
15. Hofstetter CP, Schwarz EJ, Hess D, et al. Marrow stromal cells form guiding strands in the injured spinal cord and promote recovery. Proc Natl Acad Sci USA. 2002; 99: 2199-204.
16. Cizkova D, Nagyova M, Slovinska L, et al. Response of ependymal progenitors to spinal cord injury or enhanced physical activity in adult rat. Cell Mol Neurobiol. 2009; 29: 999-1013.
17. Barnabe-Heider F, Goritz C, Sabelstrom H, et al. Origin of new glial cells in intact and injured adult spinal cord. Cell Stem Cell. 2010; 7: 470-82.
18. Sykova E, Jendelova P. Magnetic resonance tracking of implanted adult and embryonic stem cells in injured brain and spinal cord. Ann N Y Acad Sci. 2005; 1049: 146-60.
19. Kubinova S, Sykova E. Nanotechnology for treatment of stroke and spinal cord injury. Nanomedicine-UK. 2010; 5: 99-108.
20. Madigan NN, McMahon S, O'Brien T, et al. Current tissue engineering and novel therapeutic approaches to axonal regeneration following spinal cord injury using polymer scaffolds. Respir Physiol Neurobiol. 2009; 169: 183-99.
21. Blits B, Boer GJ, Verhaagen J. Pharmacological, cell, and gene therapy strategies to promote spinal cord regeneration. Cell Transplant. 2002; 11: 593-613.
22. Tetzlaff W, Okon EB, Karimi-Abdolrezaee S, et al. A systematic review of cellular transplantation therapies for spinal cord injury. J Neurotrauma. 2011; 28: 1611-82.
23. Sykova E, Jendelova P, Urdzikova L, et al. Bone marrow stem cells and polymer hydrogels-two strategies for spinal cord injury repair. Cell Mol Neurobiol. 2006; 26: 1113-29.
24. Papastefanaki F, Chen J, Lavdas AA, et al. Grafts of Schwann cells engineered to express PSA-NCAM promote functional recovery after spinal cord injury. Brain. 2007; 130: 2159-74.
25. Raisman G. Repair of spinal cord injury by transplantation of olfactory ensheathing cells. C R Biol. 2007; 330: 557-60.
26. Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell. 2006; 126: 663-76.
27. Okita K, Ichisaka T, Yamanaka S. Generation of germline-competent induced pluripotent stem cells. Nature. 2007; 448: 313-7.
28. Zhao T, Zhang ZN, Rong Z, et al. Immunogenicity of induced pluripotent stem cells. Nature. 2011; 474: 212-5.
29. Thomson JA, Odorico JS. Human embryonic stem cell and embryonic germ cell lines. Trends Biotechnol. 2000; 18: 53-7.
30. Zeng X, Rao MS. Human embryonic stem cells: long term stability, absence of senescence and a potential cell source for neural replacement. Neuroscience. 2007; 145: 1348-58.
31. Holubcova Z, Matula P, Sedlackova M, et al. Human embryonic stem cells suffer from centrosomal amplification. Stem Cells. 2011; 29: 46-56.
32. Liu S, Qu Y, Stewart TJ, et al. Embryonic stem cells differentiate into oligodendrocytes and myelinate in culture and after spinal cord transplantation. Proc Natl Acad Sci USA. 2000; 97: 6126-31.
33. Kakinohana O, Cizkova D, Tomori Z, et al. Region-specific cell grafting into cervical and lumbar spinal cord in rat: a qualitative and quantitative stereological study. Exp Neurol. 2004; 190: 122-32.
34. Lang KJ, Rathjen J, Vassilieva S, et al. Differentiation of embryonic stem cells to a neural fate: a route to re-building the nervous system? J Neurosci Res. 2004; 76: 184-92.
35. Carpenter MK, Inokuma MS, Denham J, et al. Enrichment of neurons and neural precursors from human embryonic stem cells. Exp Neurol. 2001; 172: 383-97.
36. Li XJ, Du ZW, Zarnowska ED, et al. Specification of motoneurons from human embryonic stem cells. Nat Biotechnol. 2005; 23: 215-21.
37. Keirstead HS, Nistor G, Bernal G, et al. Human embryonic stem cell-derived oligodendrocyte progenitor cell transplants remyelinate and restore locomotion after spinal cord injury. J Neurosci. 2005; 25: 4694-705.
38. Seminatore C, Polentes J, Ellman D, et al. The postischemic environment differentially impacts teratoma or tumor formation after transplantation of human embryonic stem cell-derived neural progenitors. Stroke. 2010; 41: 153-9.
39. Faulkner J, Keirstead HS. Human embryonic stem cell-derived oligodendrocyte progenitors for the treatment of spinal cord injury. Transpl Immunol. 2005; 15: 131-42.
40. Nistor GI, Totoiu MO, Haque N, et al. Human embryonic stem cells differentiate into oligodendrocytes in high purity and myelinate after spinal cord transplantation. Glia. 2005; 49: 385-96.
41. Cloutier F, Siegenthaler MM, Nistor G, et al. Transplantation of human embryonic stem cell-derived oligodendrocyte progenitors into rat spinal cord injuries does not cause harm. Regen Med. 2006; 1: 469-79.
42. Altman J. Are new neurons formed in the brains of adult mammals? Science. 1962; 135: 1127-8.
43. Gage FH. Mammalian neural stem cells. Science. 2000; 287: 1433-8.
44. Goldman S. Stem and progenitor cell-based therapy of the human central nervous system. Nat Biotechnol. 2005; 23: 862-71.
45. Horky LL, Galimi F, Gage FH, et al. Fate of endogenous stem/progenitor cells following spinal cord injury. J Comp Neurol. 2006; 498: 525-38.
46. Setoguchi T, Nakashima K, Takizawa T, et al. Treatment of spinal cord injury by transplantation of fetal neural precursor cells engineered to express BMP inhibitor. Exp Neurol. 2004; 189: 33-44.
47. Cizkova D, Cizek M, Nagyova M, et al. Enrichment of rat oligodendrocyte progenitor cells by magnetic cell sorting. J Neurosci Meth. 2009; 184: 88-94.
48. Lu P, Jones LL, Snyder EY, et al. Neural stem cells constitutively secrete neurotrophic factors and promote extensive host axonal growth after spinal cord injury. Exp Neurol. 2003; 181: 115-29.
49. Ishii K, Nakamura M, Dai H, et al. Neutralization of ciliary neurotrophic factor reduces astrocyte production from transplanted neural stem cells and promotes regeneration of corticospinal tract fibers in spinal cord injury. J Neurosci Res. 2006; 84: 1669-81.
50. Tarasenko YI, Gao J, Nie L, et al. Human fetal neural stem cells grafted into contusion-injured rat spinal cords improve behavior. J Neurosci Res. 2007; 85: 47-57.
51. Cummings BJ, Uchida N, Tamaki SJ, et al. Human neural stem cells differentiate and promote locomotor recovery in spinal cord-injured mice. Proc Natl Acad Sci USA. 2005; 102: 14069-74.
52. Marsala M, Kakinohana O, Yaksh TL, et al. Spinal implantation of hNT neurons and neuronal precursors: graft survival and functional effects in rats with ischemic spastic paraplegia. Eur J Neurosci. 2004; 20: 2401-14.
53. Wu R, Wang H, Xia X, et al. Nerve injection of viral vectors efficiently transfers transgenes into motor neurons and delivers RNAi therapy against ALS. Antioxid Redox Signal. 2009; 11: 1523-34.
54. Romanyuk N, Amemori T, Turnovcova K, et al. Using human fetal neural stem cells or human induced pluripotent stem cell-derived neural precursors for the treatment of experimental spinal cord injury. 8th IBRO World Congress of Neuroscience. Florence, Italy, 2011.
55. Hooshmand MJ, Sontag CJ, Uchida N, et al. Analysis of host-mediated repair mechanisms after human CNS-stem cell transplantation for spinal cord injury: correlation of engraftment with recovery. PLoS ONE. 2009; 4: e5871.
56. Hofstetter CP, Holmstrom NA, Lilja JA, et al. Allodynia limits the usefulness of intraspinal neural stem cell grafts; directed differentiation improves outcome. Nature Neurosci. 2005; 8: 346-53.
57. Mukhida K, Mendez I, McLeod M, et al. Spinal GABAergic transplants attenuate mechanical allodynia in a rat model of neuropathic pain. Stem Cells. 2007; 25: 2874-85.
58. Takami T, Oudega M, Bates ML, et al. Schwann cell but not olfactory ensheathing glia transplants improve hindlimb locomotor performance in the moderately contused adult rat thoracic spinal cord. J Neurosci. 2002; 22: 6670-81.
59. Pinzon A, Calancie B, Oudega M, et al. Conduction of impulses by axons regenerated in a Schwann cell graft in the transected adult rat thoracic spinal cord. J Neurosci Res. 2001; 64: 533-41.
60. Guest JD, Hiester ED, Bunge RP. Demyelination and Schwann cell responses adjacent to injury epicenter cavities following chronic human spinal cord injury. Exp Neurol. 2005; 192: 384-93.
61. Pearse DD, Sanchez AR, Pereira FC, et al. Transplantation of Schwann cells and/or olfactory ensheathing glia into the contused spinal cord: Survival, migration, axon association, and functional recovery. Glia. 2007; 55: 976-1000.
62. Bunge MB. Novel combination strategies to repair the injured mammalian spinal cord. J Spinal Cord Med. 2008; 31: 262-9.
63. Lu P, Tuszynski MH. Growth factors and combinatorial therapies for CNS regeneration. Exp Neurol. 2008; 209: 313-20.
64. Afshari FT, Kwok JC, Fawcett JW. Astrocyte-produced ephrins inhibit schwann cell migration via VAV2 signaling. J Neurosci. 2010; 30: 4246-55.
65. Mackay-Sim A. Olfactory ensheathing cells and spinal cord repair. Keio J Med. 2005; 54: 8-14.
66. Feron F, Perry C, Cochrane J, et al. Autologous olfactory ensheathing cell transplantation in human spinal cord injury. Brain. 2005; 128: 2951-60.
67. Lima C, Pratas-Vital J, Escada P, et al. Olfactory mucosa autografts in human spinal cord injury: a pilot clinical study. J Spinal Cord Med. 2006; 29: 191-203.
68. Mackay-Sim A, Feron F, Cochrane J, et al. Autologous olfactory ensheathing cell transplantation in human paraplegia: a 3-year clinical trial. Brain. 2008; 131: 2376-86.
69. Fouad K, Schnell L, Bunge MB, et al. Combining Schwann cell bridges and olfactory-ensheathing glia grafts with chondroitinase promotes locomotor recovery after complete transection of the spinal cord. J Neurosci. 2005; 25: 1169-78.
70. Amemori T, Jendelova P, Ruzickova K, et al. Co-transplantation of olfactory ensheathing glia and mesenchymal stromal cells does not have synergistic effects after spinal cord injury in the rat. Cytotherapy. 2010; 12: 212-25.
71. Salem HK, Thiemermann C. Mesenchymal stromal cells: current understanding and clinical status. Stem Cells. 2010; 28: 585-96.
72. Cizkova D, Rosocha J, Vanicky I, et al. Transplants of human mesenchymal stem cells improve functional recovery after spinal cord injury in the rat. Cell Mol Neurobiol. 2006; 26: 1167-80.
73. Sykova E, Jendelova P. Migration, fate and in vivo imaging of adult stem cells in the CNS. Cell Death Differ. 2007; 14: 1336-42.
74. Urdzikova L, Jendelova P, Glogarova K, et al. Transplantation of bone marrow stem cells as well as mobilization by granulocyte-colony stimulating factor promotes recovery after spinal cord injury in rats. J Neurotrauma. 2006; 23: 1379-91.
75. Peran M, Marchal JA, Rodriguez-Serrano F, et al. Transdifferentiation: why and how? Cell Biol Int. 2011; 35: 373-9.
76. Lambert APF, Zandonai AF, Bonatto D, et al. Differentiation of human adipose-derived adult stem cells into neuronal tissue: Does it work? Differentiation. 2009; 77: 221-8.
77. Uccelli A, Benvenuto F, Laroni A, et al. Neuroprotective features of mesenchymal stem cells. Best Pract Res Cl Ha. 2011; 24: 59-64.
78. Geffner LF, Santacruz P, Izurieta M, et al. Administration of autologous bone marrow stem cells into spinal cord injury patients via multiple routes is safe and improves their quality of life: comprehensive case studies. Cell Transplant. 2008; 17: 1277-93.
79. Park HC, Shim YS, Ha Y, et al. Treatment of complete spinal cord injury patients by autologous bone marrow cell transplantation and administration of granulocyte-macrophage colony stimulating factor. Tissue Eng. 2005; 11: 913-22.
80. Yoon SH, Shim YS, Park YH, et al. Complete spinal cord injury treatment using autologous bone marrow cell transplantation and bone marrow stimulation with granulocyte macrophage-colony stimulating factor: Phase I/II clinical trial. Stem Cells. 2007; 25: 2066-73.
81. Callera F, do Nascimento RX. Delivery of autologous bone marrow precursor cells into the spinal cord via lumbar puncture technique in patients with spinal cord injury: a preliminary safety study. Exp Hematol. 2006; 34: 130-1.
82. Deda H, Inci MC, Kurekci AE, et al. Treatment of chronic spinal cord injured patients with autologous bone marrow-derived hematopoietic stem cell transplantation: 1-year follow-up. Cytotherapy. 2008; 10: 565-74.
83. Saito F, Nakatani T, Iwase M, et al. Spinal cord injury treatment with intrathecal autologous bone marrow stromal cell transplantation: the first clinical trial case report. J Trauma. 2008; 64: 53-9.
84. Pal R, Venkataramana NK, Bansal A, et al. Ex vivo-expanded autologous bone marrow-derived mesenchymal stromal cells in human spinal cord injury/paraplegia: a pilot clinical study. Cytotherapy. 2009; 11: 897-911.
85. Mason MR, Ehlert EM, Eggers R, et al. Comparison of AAV serotypes for gene delivery to dorsal root ganglion neurons. Mol Ther. 2010; 18: 715-24.
86. Petruska JC, Kitay B, Boyce VS, et al. Intramuscular AAV delivery of NT-3 alters synaptic transmission to motoneurons in adult rats. Eur J Neurosci. 2010; 32: 997-1005.
87. Tuszynski MH. Nerve growth factor gene delivery: animal models to clinical trials. Dev Neurobiol. 2007; 67: 1204-15.
88. Blits B, Derks S, Twisk J, et al. Adeno-associated viral vector (AAV)-mediated gene transfer in the red nucleus of the adult rat brain: comparative analysis of the transduction properties of seven AAV serotypes and lentiviral vectors. J Neurosci Meth. 2010; 185: 257-63.
89. Aalbers CJ, Tak PP, Vervoordeldonk MJ. Advancements in adeno-associated viral gene therapy approaches: exploring a new horizon. F1000 Med Reports. 2011; 3: 17.
90. Straley KS, Foo CWP, Heilshorn SC. Biomaterial design strategies for the treatment of spinal cord injuries. J Neurotrauma. 2010; 27: 1-19.
91. Hejcl A, Lesny P, Pradny M, et al. Biocompatible hydrogels in spinal cord injury repair. Physiol Res. 2008; 57: S121-32.
92. Friedman JA, Windebank AJ, Moore MJ, et al. Biodegradable polymer grafts for surgical repair of the injured spinal cord. Neurosurgery. 2002; 51: 742-52.
93. De Laporte L, Lei Yan A, Shea LD. Local gene delivery from ECM-coated poly(lactide-co-glycolide) multiple channel bridges after spinal cord injury. Biomaterials. 2009; 30: 2361-8.
94. Wong DY, Leveque JC, Brumblay H, et al. Macro-architectures in spinal cord scaffold implants influence regeneration. J Neurotrauma. 2008; 25: 1027-37.
95. Pêgo AP, Poot AA, Grijpma DW, et al. Copolymers of trimethylene carbonate and epsilon-caprolactone for porous nerve guides: Synthesis and properties. J Biomat Sci-Polym E. 2001; 12: 35-53.
96. Tsai EC, Dalton PD, Shoichet MS, et al. Synthetic hydrogel guidance channels facilitate regeneration of adult rat brainstem motor axons after complete spinal cord transection. J Neurotrauma. 2004; 21: 789-804.
97. Woerly S, Fort S, Pignot-Paintrand I, et al. Development of a sialic acid-containing hydrogel of poly[N-(2-hydroxypropyl) methacrylamide]: characterization and implantation study. Biomacromolecules. 2008; 9: 2329-37.
98. Collazos-Castro JE, Polo JL, Hernandez-Labrado GR, et al. Bioelectrochemical control of neural cell development on conducting polymers. Biomaterials. 2010; 31: 9244-55.
99. Ciardelli G, Chiono V. Materials for peripheral nerve regeneration. Macromol Biosci. 2006; 6: 13-26.
100. Yoshii S, Ito S, Shima M, et al. Functional restoration of rabbit spinal cord using collagen-filament scaffold. J Tissue Eng Regen M. 2009; 3: 19-25.
101. Taylor SJ, McDonald III JW, Sakiyama-Elbert SE. Controlled release of neurotrophin-3 from fibrin gels for spinal cord injury. J Control Release. 2004; 98: 281-94.
102. Pêgo AP, Mar FM, Rocha DN, et al. Scaffold-driven regenerative therapy for the spinal cord injury - biomimeting neurogenesis in the CNS. Histol Histopathol. 2011; 26: 289.
103. Wei YT, He Y, Xu CL, et al. Hyaluronic acid hydrogel modified with nogo-66 receptor antibody and poly-L-lysine to promote axon regrowth after spinal cord injury. J Biomed Mater Res B. 2010; 95: 110-7.
104. Park J, Lim E, Back S, et al. Nerve regeneration following spinal cord injury using matrix metalloproteinase-sensitive, hyaluronic acid-based biomimetic hydrogel scaffold containing brain-derived neurotrophic factor. J Biomed Mater Res A. 2010; 93: 1091-9.
105. Gros T, Sakamoto JS, Blesch A, et al. Regeneration of long-tract axons through sites of spinal cord injury using templated agarose scaffolds. Biomaterials. 2010; 31: 6719-29.
106. Prang P, Muller R, Eljaouhari A, et al. The promotion of oriented axonal regrowth in the injured spinal cord by alginate-based anisotropic capillary hydrogels. Biomaterials. 2006; 27: 3560-9.
107. Bozkurt G, Mothe AJ, Zahir T, et al. Chitosan channels containing spinal cord-derived stem/progenitor cells for repair of subacute spinal cord injury in the rat. Neurosurgery. 2010; 67: 1733-44.
108. Shen Y, Qian Y, Zhang H, et al. Guidance of olfactory ensheathing cell growth and migration on electrospun silk fibroin scaffolds. Cell Transplant. 2010; 19: 147-57.
109. Novikova LN, Pettersson J, Brohlin M, et al. Biodegradable poly-beta-hydroxybutyrate scaffold seeded with Schwann cells to promote spinal cord repair. Biomaterials. 2008; 29: 1198-206.
110. Bhattarai N, Li Z, Gunn J, et al. Natural-synthetic polyblend nanofibers for biomedical applications. Adv Mater. 2009; 21: 2792-7.
111. Hejcl A, Lesny P, Pradny M, et al. Macroporous hydrogels based on 2-hydroxyethyl methacrylate. Part 6: 3D hydrogels with positive and negative surface charges and polyelectrolyte complexes in spinal cord injury repair. J Mater Sci Mater Med. 2009; 20: 1571-7.
112. Kubinova S, Horak D, Sykova E. Cholesterol-modified superporous poly(2-hydroxyethyl methacrylate) scaffolds for tissue engineering. Biomaterials. 2009; 30: 4601-9.
113. Kubinova S, Horak D, Hejcl A, et al. Highly superporous cholesterol-modified poly(2-hydroxyethyl methacrylate) scaffolds for spinal cord injury repair. J Biomed Mater Res A. 2011; 99: 618-29.
114. Gunn JW, Turner SD, Mann BK. Adhesive and mechanical properties of hydrogels influence neurite extension. J Biomed Mater Res A. 2005; 72: 91-7.
115. Kubinova S, Horak D, Kozubenko N, et al. The use of superporous Ac-CGGASIKVAVS-OH-modified PHEMA scaffolds to promote cell adhesion and the differentiation of human fetal neural precursors. Biomaterials. 2010; 31: 5966-75.
116. Cui H, Webber MJ, Stupp SI. Self-assembly of peptide amphiphiles: from molecules to nanostructures to biomaterials. Biopolymers. 2010; 94: 1-18.
117. Tysseling-Mattiace VM, Sahni V, Niece KL, et al. Self-assembling nanofibers inhibit glial scar formation and promote axon elongation after spinal cord injury. J Neurosci. 2008; 28: 3814-23.
118. Bellamkonda R, Ranieri JP, Bouche N, et al. Hydrogel-based three-dimensional matrix for neural cells. J Biomed Mater Res. 1995; 29: 663-71.
119. Wang M, Zhai P, Chen X, et al. Bioengineered scaffolds for spinal cord repair. Tissue Eng Pt B-Rev. 2011; 17: 177-94.
120. Stokols S, Sakamoto J, Breckon C, et al. Templated agarose scaffolds support linear axonal regeneration. Tissue Eng. 2006; 12: 2777-87.
121. Stokols S, Tuszynski MH. Freeze-dried agarose scaffolds with uniaxial channels stimulate and guide linear axonal growth following spinal cord injury. Biomaterials. 2006; 27: 443-51.
122. Moore MJ, Friedman JA, Lewellyn EB, et al. Multiple-channel scaffolds to promote spinal cord axon regeneration. Biomaterials. 2006; 27: 419-29.
123. Wang HB, Mullins ME, Cregg JM, et al. Creation of highly aligned electrospun poly-L-lactic acid fibers for nerve regeneration applications. J Neural Eng. 2009; 6: 016001.
124. Wang HB, Mullins ME, Cregg JM, et al. Varying the diameter of aligned electrospun fibers alters neurite outgrowth and Schwann cell migration. Acta Biomater. 2010; 6: 2970-8.
125. Xie J, MacEwan MR, Li X, et al. Neurite outgrowth on nanofiber scaffolds with different orders, structures, and surface properties. ACS Nano. 2009; 3: 1151-9.
126. Hurtado A, Cregg JM, Wang HB, et al. Robust CNS regeneration after complete spinal cord transection using aligned poly-l-lactic acid microfibers. Biomaterials. 2011; 32: 6068-79.
127. Guo J, Su H, Zeng Y, et al. Reknitting the injured spinal cord by self-assembling peptide nanofiber scaffold. Nanomedicine. 2007; 3: 311-21.
128. Johnson PJ, Tatara A, McCreedy DA, et al. Tissue-engineered fibrin scaffolds containing neural progenitors enhance functional recovery in a subacute model of SCI. Soft Matter. 2010; 6: 5127-37.
129. Olson HE, Rooney GE, Gross L, et al. Neural stem cell- and Schwann cell-loaded biodegradable polymer scaffolds support axonal regeneration in the transected spinal cord. Tissue Eng Pt A. 2009; 15: 1797-805.
130. Hurtado A, Moon LD, Maquet V, et al. Poly (D, L-lactic acid) macroporous guidance scaffolds seeded with Schwann cells genetically modified to secrete a bi-functional neurotrophin implanted in the completely transected adult rat thoracic spinal cord. Biomaterials. 2006; 27: 430-42.
131. Woerly S, Pinet E, de Robertis L, et al. Spinal cord repair with PHPMA hydrogel containing RGD peptides (NeuroGel). Biomaterials. 2001; 22: 1095-111.
132. Loh NK, Woerly S, Bunt SM, et al. The regrowth of axons within tissue defects in the CNS is promoted by implanted hydrogel matrices that contain BDNF and CNTF producing fibroblasts. Exp Neurol. 2001; 170: 72-84.
133. Hejcl A, Sedy J, Kapcalova M, et al. HPMA-RGD hydrogels seeded with mesenchymal stem cells improve functional outcome in chronic spinal cord injury. Stem Cells Dev. 2010; 19: 1535-46.
134. Willerth SM, Sakiyama-Elbert SE. Approaches to neural tissue engineering using scaffolds for drug delivery. Adv Drug Deliv Rev. 2007; 59: 325-38.
135. Jimenez Hamann MC, Tator CH, Shoichet MS. Injectable intrathecal delivery system for localized administration of EGF and FGF-2 to the injured rat spinal cord. Exp Neurol. 2005; 194: 106-19.
136. Jain A, Kim YT, McKeon RJ, et al. In situ gelling hydrogels for conformal repair of spinal cord defects, and local delivery of BDNF after spinal cord injury. Biomaterials. 2006; 27: 497-504.
137. Piantino J, Burdick JA, Goldberg D, et al. An injectable, biodegradable hydrogel for trophic factor delivery enhances axonal rewiring and improves performance after spinal cord injury. Exp Neurol. 2006; 201: 359-67.
138. Hendriks WT, Ruitenberg MJ, Blits B, et al. Viral vector-mediated gene transfer of neurotrophins to promote regeneration of the injured spinal cord. Prog Brain Res. 2004; 146: 451-76.
139. Abdellatif AA, Pelt JL, Benton RL, et al. Gene delivery to the spinal cord: comparison between lentiviral, adenoviral, and retroviral vector delivery systems. J Neurosci Res. 2006; 84: 553-67.
140. Blits B, Bunge MB. Direct gene therapy for repair of the spinal cord. J Neurotrauma. 2006; 23: 508-20.
141. Oliveira H, Fernandez R, Pires LR, et al. Targeted gene delivery into peripheral sensorial neurons mediated by self-assembled vectors composed of poly(ethylene imine) and tetanus toxin fragment c. J Control Release. 2010; 143: 350-8.
142. Oliveira H, Pires LR, Fernandez R, et al. Chitosan-based gene delivery vectors targeted to the peripheral nervous system. J Biomed Mater Res A. 2010; 95: 801-10.
143. Whitehead KA, Langer R, Anderson DG. Knocking down barriers: advances in siRNA delivery. Nat Rev Drug Discov. 2009; 8: 129-38.
144. Mittnacht U, Hartmann H, Hein S, et al. Chitosan/siRNA nanoparticles biofunctionalize nerve implants and enable neurite outgrowth. Nano Lett. 2010; 10: 3933-9.
145. Richardson PM, McGuinness UM, Aguayo AJ. Axons from CNS neurons regenerate into PNS grafts. Nature. 1980; 284: 264-5.
146. David S, Aguayo AJ. Axonal elongation into peripheral nervous system "bridges" after central nervous system injury in adult rats. Science. 1981; 214: 931-3.
147. Schweigreiter R. The natural history of the myelin-derived nerve growth inhibitor Nogo-A. Neuron Glia Biol. 2008; 4: 83-9.
148. Vargas ME, Barres BA. Why is Wallerian degeneration in the CNS so slow? Annu Rev Neurosci. 2007; 30: 153-79.
149. Neumann S, Woolf CJ. Regeneration of dorsal column fibers into and beyond the lesion site following adult spinal cord injury. Neuron. 1999; 23: 83-91.
150. Ylera B, Erturk A, Hellal F, et al. Chronically CNS-injured adult sensory neurons gain regenerative competence upon a lesion of their peripheral axon. Curr Biol. 2009; 19: 930-6.
151. Qiu J, Cai D, Dai H, et al. Spinal axon regeneration induced by elevation of cyclic AMP. Neuron. 2002; 34: 895-903.
152. Jacob JM, Croes SA. Acceleration of axonal outgrowth in motor axons from mature and old F344 rats after a conditioning lesion. Exp Neurol. 1998; 152: 231-7.
153. McQuarrie IG, Grafstein B. Effect of a conditioning lesion on optic nerve regeneration in goldfish. Brain Res. 1981; 216: 253-64.
154. Neumann S, Bradke F, Tessier-Lavigne M, et al. Regeneration of sensory axons within the injured spinal cord induced by intraganglionic cAMP elevation. Neuron. 2002; 34: 885-93.
155. Zou H, Ho C, Wong K, et al. Axotomy-induced Smad1 activation promotes axonal growth in adult sensory neurons. J Neurosci. 2009; 29: 7116-23.
156. Seijffers R, Mills CD, Woolf CJ. ATF3 increases the intrinsic growth state of DRG neurons to enhance peripheral nerve regeneration. J Neurosci. 2007; 27: 7911-20.
157. Cafferty WB, Gardiner NJ, Gavazzi I, et al. Leukemia inhibitory factor determines the growth status of injured adult sensory neurons. J Neurosci. 2001; 21: 7161-70.
158. Cafferty WB, Gardiner NJ, Das P, et al. Conditioning injury-induced spinal axon regeneration fails in interleukin-6 knock-out mice. J Neurosci. 2004; 24: 4432-43.
159. Cao Z, Gao Y, Bryson JB, et al. The cytokine interleukin-6 is sufficient but not necessary to mimic the peripheral conditioning lesion effect on axonal growth. J Neurosci. 2006; 26: 5565-73.
160. Minor K, Phillips J, Seeds NW. Tissue plasminogen activator promotes axonal outgrowth on CNS myelin after conditioned injury. J Neurochem. 2009; 109: 706-15.
161. Pearse DD, Pereira FC, Marcillo AE, et al. cAMP and Schwann cells promote axonal growth and functional recovery after spinal cord injury. Nat Med. 2004; 10: 610-6.
162. Nikulina E, Tidwell JL, Dai HN, et al. The phosphodiesterase inhibitor rolipram delivered after a spinal cord lesion promotes axonal regeneration and functional recovery. Proc Natl Acad Sci USA. 2004; 101: 8786-90.
163. Cai D, Deng K, Mellado W, et al. Arginase I and polyamines act downstream from cyclic AMP in overcoming inhibition of axonal growth MAG and myelin in vitro. Neuron. 2002; 35: 711-9.
164. Ma TC, Campana A, Lange PS, et al. A large-scale chemical screen for regulators of the arginase 1 promoter identifies the soy isoflavone daidzeinas a clinically approved small molecule that can promote neuronal protection or regeneration via a cAMP-independent pathway. J Neurosci. 2010; 30: 739-48.
165. Bregman BS, Kunkel-Bagden E, Schnell L, et al. Recovery from spinal cord injury mediated by antibodies to neurite growth inhibitors. Nature. 1995; 378: 498-501.
166. Bradbury EJ, Moon LD, Popat RJ, et al. Chondroitinase ABC promotes functional recovery after spinal cord injury. Nature. 2002; 416: 636-40.
167. Bareyre FM, Kerschensteiner M, Raineteau O, et al. The injured spinal cord spontaneously forms a new intraspinal circuit in adult rats. Nature Neurosci. 2004; 7: 269-77.
168. Saberi H, Firouzi M, Habibi Z, et al. Safety of intramedullary Schwann cell transplantation for postrehabilitation spinal cord injuries: 2-year follow-up of 33 cases. J Neurosurg Spine. 2011; 15: 515-25.
169. Fukushima K, Enomoto M, Tomizawa S, et al. The axonal regeneration across a honeycomb collagen sponge applied to the transected spinal cord. J Med Dent Sci. 2008; 55: 71-9.
170. Madaghiele M, Sannino A, Yannas IV, et al. Collagen-based matrices with axially oriented pores. J Biomed Mater Res A. 2008; 85: 757-67.
171. Liang W, Han Q, Jin W, et al. The promotion of neurological recovery in the rat spinal cord crushed injury model by collagen-binding BDNF. Biomaterials. 2010; 31: 8634-41.
172. Liu T, Houle JD, Xu J, et al. Nanofibrous Collagen Nerve Conduits for Spinal Cord Repair. Tissue Eng Pt A. 2012; 18: 1057-66.
173. Khaing ZZ, Milman BD, Vanscoy JE, et al. High molecular weight hyaluronic acid limits astrocyte activation and scar formation after spinal cord injury. J Neural Eng. 2011; 8: 046033.
174. Mehrotra S, Lynam D, Maloney R, et al. Time Controlled Protein Release from Layer-by-Layer Assembled Multilayer Functionalized Agarose Hydrogels. Adv Funct Mater. 2010; 20: 247-58.
175. Kataoka K, Suzuki Y, Kitada M, et al. Alginate enhances elongation of early regenerating axons in spinal cord of young rats. Tissue Eng. 2004; 10: 493-504.
176. Chen X, Yang Y, Yao J, et al. Bone marrow stromal cells-loaded chitosan conduits promote repair of complete transection injury in rat spinal cord. J Mater Sci Mater Med. 2011; 22: 2347-56.
177. Kim H, Tator CH, Shoichet MS. Chitosan implants in the rat spinal cord: biocompatibility and biodegradation. J Biomed Mater Res A. 2011; 97: 395-404.
178. Ding C, Guo X, Cheng B, et al. Fabrication and radial compressive properties of the biodegradable woven regeneration conduits for peripheral nerve repair. Adv Mat Res. 2011; 332-334: 1481-4.
179. Suwantong O, Waleetorncheepsawat S, Sanchavanakit N, et al. In vitro biocompatibility of electrospun poly(3-hydroxybutyrate) and poly(3-hydroxybutyrate-co-3-hydroxyvalerate) fiber mats. Int J Biol Macromol. 2007; 40: 217-23.
180. Pritchard CD, Slotkin JR, Yu D, et al. Establishing a model spinal cord injury in the African green monkey for the preclinical evaluation of biodegradable polymer scaffolds seeded with human neural stem cells. J Neurosci Meth. 2010; 188: 258-69.
181. Pires LR, Guarino V, Barrias CC, et al. Tunning poly(trymethylene carbonate-co-epsilon-caprolactone) fibers for nerve regeneration. Histol Histopathol. 2011; 26: 251-2.
182. Tysseling VM, Sahni V, Pashuck ET, et al. Self-assembling peptide amphiphile promotes plasticity of serotonergic fibers following spinal cord injury. J Neurosci Res. 2010; 88: 3161-70.